In vivo administration of interleukin-2 protects susceptible mice from Theiler's virus persistence.
In vivo administration of interleukin-2 (IL-2)-secreting tumor cells results in complete protection against persistent infection by Theiler's murine encephalomyelitis virus (TMEV) in susceptible DBA/2 mice. The IL-2-mediated protection was found to depend on the inoculum size as well as the timing o...
Na minha lista:
| 發表在: | J Virol |
|---|---|
| Principais autores: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Microbiology (ASM)
1997
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC191120/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8985419/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.71.1.797-799.1997 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|